Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin 23”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)WithdrawnNCT04655807
What this trial is testing

JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC
Not applicableStudy completedNCT06844565
What this trial is testing

Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease

Who this might be right for
Interleukin 12Interleukin 23Biomarker+2 more
Tanta University 110
Not applicableLooking for participantsNCT05290363
What this trial is testing

The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis

Who this might be right for
Spondyloarthritis
Institut Pasteur 90
Large-scale testing (Phase 3)Ended earlyNCT03556202
What this trial is testing

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,936
Not applicableLooking for participantsNCT07234838
What this trial is testing

Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)

Who this might be right for
PsoriasisCondyloma AcuminataBiotherapies
Jonathan Krygier 600
Large-scale testing (Phase 3)Study completedNCT03535194
What this trial is testing

Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,484
Very early researchStudy completedNCT04971200
What this trial is testing

Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo

Who this might be right for
Skin and Connective Tissue DiseasesSkin DiseasesPigmentation Disorder+3 more
Premier Specialists, Australia 12
Testing effectiveness (Phase 2)Study completedNCT04004611
What this trial is testing

Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 26
Large-scale testing (Phase 3)Study completedNCT03524092
What this trial is testing

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,328
Early research (Phase 1)Looking for participantsNCT06287528
What this trial is testing

19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more
Memorial Sloan Kettering Cancer Center 18
Not applicableNot Yet RecruitingNCT07184138
What this trial is testing

Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China

Who this might be right for
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Sixth Affiliated Hospital, Sun Yat-sen University 178
Testing effectiveness (Phase 2)Study completedNCT03975153
What this trial is testing

Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

Who this might be right for
Pityriasis Rubra Pilaris
Oregon Health and Science University 15
Not applicableLooking for participantsNCT07661784
What this trial is testing

Salivary Biomarkers in Periodontal Disease Progression

Who this might be right for
Periodontal DiseaseGingivitis and Periodontal DiseasesPeriodontitis
Suleyman Demirel University 240
Large-scale testing (Phase 3)Study completedNCT03518086
What this trial is testing

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,281
Post-approval studies (Phase 4)Not Yet RecruitingNCT07782021
What this trial is testing

MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's Disease

Who this might be right for
Crohn's DiseasePerianal Fistula
Icahn School of Medicine at Mount Sinai 50
Testing effectiveness (Phase 2)Looking for participantsNCT06598943
What this trial is testing

Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 143
Post-approval studies (Phase 4)Looking for participantsNCT07216014
What this trial is testing

Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

Who this might be right for
Crohn's Disease and Ulcerative Colitis
Sixth Affiliated Hospital, Sun Yat-sen University 200
Large-scale testing (Phase 3)Study completedNCT00307437
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 1,230
Not applicableLooking for participantsNCT06006039
What this trial is testing

The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.

Who this might be right for
Crohn´s Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Not applicableLooking for participantsNCT06792487
What this trial is testing

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

Who this might be right for
Psoriasis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Next Page